Palatin Technologies, Inc. stock is up 42.5% since 30 days ago. The next earnings date is Feb 14, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25.93% of the previous 26 December’s closed higher than November.
Palatin Technologies, Inc. develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the. treatment of premenopausal women with hypoactive sexual desire disorder.